Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alfred Witjes

Showing results (41-50 of 378) with videos related to

Pageof 38
Sort By:
European Urology|June 14, 2011
Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic reviewSven van den Bosch, J Alfred Witjes
Expert Review of Anticancer Therapy|June 29, 2011
Discussion on the influence of HER2 status on the clinical outcome of bladder cancer continuesRianne J M Lammers, J Alfred Witjes
Current Opinion in Urology|July 27, 2010
Follow-up of patients after curative bladder cancer treatment: guidelines vs. practiceOlaf P J Vrooman, J Alfred Witjes
International Journal of Urology : Official Journal of the Japanese Urological Association|March 21, 2009
Molecular markers for detection, surveillance and prognostication of bladder cancerOlaf P J Vrooman, J Alfred Witjes
European Urology|October 1, 2018
Reply to Harshit Garg, Brusabhanu Nayak and Prabhjot Singh's Letter to the Editor Re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046-52Tom J H Arends, J Alfred Witjes
Current Opinion in Urology|August 15, 2003
Future strategies in the diagnosis, staging and treatment of bladder cancerAntoine G van der Heijden, J Alfred Witjes
European Urology Oncology|April 19, 2020
Vesical Imaging-Reporting and Data System (VI-RADS) for Bladder Cancer Diagnostics: The Replacement for Surgery?Antoine G van der Heijden, J Alfred Witjes
World Journal of Urology|May 31, 2007
The impact of obesity on prostate cancerJoep G H van Roermund, J Alfred Witjes
European Urology|January 22, 2008
The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trialsRichard J Sylvester, Willem Oosterlinck, J Alfred Witjes
European Urology|October 6, 2022
Positron Emission Tomography/Computed Tomography for Staging of Bladder Cancer: A Continuing Clinical ControversyLaura S Mertens, Richard P Meijer, J Alfred Witjes
Pageof 38

Showing results (41-50 of 378) with videos related to

Sort By:
Pageof 38
European Urology|June 14, 2011
Long-term cancer-specific survival in patients with high-risk, non-muscle-invasive bladder cancer and tumour progression: a systematic reviewSven van den Bosch, J Alfred Witjes
Expert Review of Anticancer Therapy|June 29, 2011
Discussion on the influence of HER2 status on the clinical outcome of bladder cancer continuesRianne J M Lammers, J Alfred Witjes
Current Opinion in Urology|July 27, 2010
Follow-up of patients after curative bladder cancer treatment: guidelines vs. practiceOlaf P J Vrooman, J Alfred Witjes
International Journal of Urology : Official Journal of the Japanese Urological Association|March 21, 2009
Molecular markers for detection, surveillance and prognostication of bladder cancerOlaf P J Vrooman, J Alfred Witjes
European Urology|October 1, 2018
Reply to Harshit Garg, Brusabhanu Nayak and Prabhjot Singh's Letter to the Editor Re: Tom J.H. Arends, Ofer Nativ, Massimo Maffezzini, et al. Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guerin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer. Eur Urol 2016;69:1046-52Tom J H Arends, J Alfred Witjes
Current Opinion in Urology|August 15, 2003
Future strategies in the diagnosis, staging and treatment of bladder cancerAntoine G van der Heijden, J Alfred Witjes
European Urology Oncology|April 19, 2020
Vesical Imaging-Reporting and Data System (VI-RADS) for Bladder Cancer Diagnostics: The Replacement for Surgery?Antoine G van der Heijden, J Alfred Witjes
World Journal of Urology|May 31, 2007
The impact of obesity on prostate cancerJoep G H van Roermund, J Alfred Witjes
European Urology|January 22, 2008
The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trialsRichard J Sylvester, Willem Oosterlinck, J Alfred Witjes
European Urology|October 6, 2022
Positron Emission Tomography/Computed Tomography for Staging of Bladder Cancer: A Continuing Clinical ControversyLaura S Mertens, Richard P Meijer, J Alfred Witjes
Pageof 38